by Cal Strode | Mar 11, 2025
“Every administration has its headwinds and tailwinds” said Tim Hunt, CEO, Alliance for Regenerative Medicine (ARM), when examining the impact of the two most recent U.S. administrations at ARM’s 2025 State of the Industry Briefing in January. Credit: Alliance for...
by Lyla El-Fayomi | Feb 24, 2025
I’m back with a post-holiday double edition of RMNU🔬! I cover stem cell patches for failing hearts, a novel skeletal tissue that’s been (re-)discovered, an update on BlueRock’s Parkinson’s therapy, and more. Bookmark, or dive right in! Pick of the Month(s) Stem cell...
by Laya Kiani | Sep 26, 2024
The regenerative medicine (RM) market is highly competitive, with major biopharmaceutical companies and innovative startups vying for dominance. As companies seek regulatory approval and work to establish their presence in this fast-evolving industry, the competitive...
by Stacey Johnson | Jan 26, 2024
When does Mardi Gras come to Miami, Florida? When it’s Advanced Therapies Week (ATW). The industry-focused conference was back at the Miami Convention Centre in South Beach, but possibly for the last time as the conference is moving to San Diego next year. That may...
by Cal Strode | Jan 18, 2024
About a year ago today, I covered the 2023 Alliance for Regenerative Medicine (ARM) State of the Industry Briefing for Signals. The briefing placed strong emphasis on the industry’s acceleration, driven by scientific advances that are bringing meaningful developments...
Comments